CID 54758501

Olmutinib

Structural Information

Molecular Formula
C26H26N6O2S
SMILES
CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)SC=C4
InChI
InChI=1S/C26H26N6O2S/c1-3-23(33)27-19-5-4-6-21(17-19)34-25-24-22(11-16-35-24)29-26(30-25)28-18-7-9-20(10-8-18)32-14-12-31(2)13-15-32/h3-11,16-17H,1,12-15H2,2H3,(H,27,33)(H,28,29,30)
InChIKey
FDMQDKQUTRLUBU-UHFFFAOYSA-N
Compound name
N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide
Related CIDs

2D Structure

compound 2d structure
5
Annotation Hits

34
References

2512
Patents

486.1838 Da
Monoisotopic Mass

4.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 487.19108 213.2
[M+Na]+ 509.17302 219.4
[M-H]- 485.17652 221.5
[M+NH4]+ 504.21762 217.2
[M+K]+ 525.14696 210.9
[M+H-H2O]+ 469.18106 201.1
[M+HCOO]- 531.18200 225.4
[M+CH3COO]- 545.19765 219.5
[M+Na-2H]- 507.15847 213.7
[M]+ 486.18325 213.6
[M]- 486.18435 213.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe